Selected research
Industry Research
Poloxamer Industry Research Report 2026
Market perspective
The global Poloxamer market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Poloxamer is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Poloxamer is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Poloxamer is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Poloxamer include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Poloxamer market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Poloxamer.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Poloxamer Market by Company
BASF
ADEKA
Croda
Nanjing Well
Hubei Hengshuo
Solvay
Merck KGaA
Poloxamer Segment by Type
Poloxamer 124
Poloxamer 184
Poloxamer 188
Poloxamer 338
Poloxamer 407
Others
Poloxamer Segment by Application
Cosmetics Industrial
Biologics
Pharmaceutical Industrial
Others
Poloxamer Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poloxamer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Poloxamer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poloxamer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Poloxamer manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Poloxamer by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Poloxamer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Poloxamer 124
- Poloxamer 184
- Poloxamer 188
- Poloxamer 338
- Poloxamer 407
- Others
Applications
- Cosmetics Industrial
- Biologics
- Pharmaceutical Industrial
- Others
Companies covered
- BASF
- ADEKA
- Croda
- Nanjing Well
- Hubei Hengshuo
- Solvay
- Merck KGaA
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Poloxamer by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Poloxamer 124
- 2.2.3 Poloxamer 184
- 2.2.4 Poloxamer 188
- 2.2.5 Poloxamer 338
- 2.2.6 Poloxamer 407
- 2.2.7 Others
- 2.3 Poloxamer by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Cosmetics Industrial
- 2.3.3 Biologics
- 2.3.4 Pharmaceutical Industrial
- 2.3.5 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Poloxamer Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Poloxamer Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Poloxamer Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Poloxamer Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Poloxamer Production by Manufacturers (2021-2026)
- 3.2 Global Poloxamer Production Value by Manufacturers (2021-2026)
- 3.3 Global Poloxamer Average Price by Manufacturers (2021-2026)
- 3.4 Global Poloxamer Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Poloxamer Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Poloxamer Manufacturers, Product Type & Application
- 3.7 Global Poloxamer Manufacturers Established Date
- 3.8 Global Poloxamer Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BASF
- 4.1.1 BASF Poloxamer Company Information
- 4.1.2 BASF Poloxamer Business Overview
- 4.1.3 BASF Poloxamer Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 BASF Product Portfolio
- 4.1.5 BASF Recent Developments
- 4.2 ADEKA
- 4.2.1 ADEKA Poloxamer Company Information
- 4.2.2 ADEKA Poloxamer Business Overview
- 4.2.3 ADEKA Poloxamer Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 ADEKA Product Portfolio
- 4.2.5 ADEKA Recent Developments
- 4.3 Croda
- 4.3.1 Croda Poloxamer Company Information
- 4.3.2 Croda Poloxamer Business Overview
- 4.3.3 Croda Poloxamer Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Croda Product Portfolio
- 4.3.5 Croda Recent Developments
- 4.4 Nanjing Well
- 4.4.1 Nanjing Well Poloxamer Company Information
- 4.4.2 Nanjing Well Poloxamer Business Overview
- 4.4.3 Nanjing Well Poloxamer Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Nanjing Well Product Portfolio
- 4.4.5 Nanjing Well Recent Developments
- 4.5 Hubei Hengshuo
- 4.5.1 Hubei Hengshuo Poloxamer Company Information
- 4.5.2 Hubei Hengshuo Poloxamer Business Overview
- 4.5.3 Hubei Hengshuo Poloxamer Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Hubei Hengshuo Product Portfolio
- 4.5.5 Hubei Hengshuo Recent Developments
- 4.6 Solvay
- 4.6.1 Solvay Poloxamer Company Information
- 4.6.2 Solvay Poloxamer Business Overview
- 4.6.3 Solvay Poloxamer Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Solvay Product Portfolio
- 4.6.5 Solvay Recent Developments
- 4.7 Merck KGaA
- 4.7.1 Merck KGaA Poloxamer Company Information
- 4.7.2 Merck KGaA Poloxamer Business Overview
- 4.7.3 Merck KGaA Poloxamer Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Merck KGaA Product Portfolio
- 4.7.5 Merck KGaA Recent Developments
5 Global Poloxamer Production by Region
- 5.1 Global Poloxamer Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Poloxamer Production by Region: 2021-2032
- 5.2.1 Global Poloxamer Production by Region: 2021-2026
- 5.2.2 Global Poloxamer Production Forecast by Region (2027-2032)
- 5.3 Global Poloxamer Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Poloxamer Production Value by Region: 2021-2032
- 5.4.1 Global Poloxamer Production Value by Region: 2021-2026
- 5.4.2 Global Poloxamer Production Value Forecast by Region (2027-2032)
- 5.5 Global Poloxamer Market Price Analysis by Region (2021-2026)
- 5.6 Global Poloxamer Production and Value, YOY Growth
- 5.6.1 North America Poloxamer Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Poloxamer Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Poloxamer Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Poloxamer Production Value Estimates and Forecasts (2021-2032)
6 Global Poloxamer Consumption by Region
- 6.1 Global Poloxamer Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Poloxamer Consumption by Region (2021-2032)
- 6.2.1 Global Poloxamer Consumption by Region: 2021-2026
- 6.2.2 Global Poloxamer Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Poloxamer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Poloxamer Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.4 Europe
- 6.4.1 Europe Poloxamer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Poloxamer Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Poloxamer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Poloxamer Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 China Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Poloxamer Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Poloxamer Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Poloxamer Production by Type (2021-2032)
- 7.1.1 Global Poloxamer Production by Type (2021-2032) & (Tons)
- 7.1.2 Global Poloxamer Production Market Share by Type (2021-2032)
- 7.2 Global Poloxamer Production Value by Type (2021-2032)
- 7.2.1 Global Poloxamer Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Poloxamer Production Value Market Share by Type (2021-2032)
- 7.3 Global Poloxamer Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Poloxamer Production by Application (2021-2032)
- 8.1.1 Global Poloxamer Production by Application (2021-2032) & (Tons)
- 8.1.2 Global Poloxamer Production Market Share by Application (2021-2032)
- 8.2 Global Poloxamer Production Value by Application (2021-2032)
- 8.2.1 Global Poloxamer Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Poloxamer Production Value Market Share by Application (2021-2032)
- 8.3 Global Poloxamer Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Poloxamer Value Chain Analysis
- 9.1.1 Poloxamer Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Poloxamer Production Mode & Process
- 9.2 Poloxamer Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Poloxamer Distributors
- 9.2.3 Poloxamer Customers
10 Global Poloxamer Analyzing Market Dynamics
- 10.1 Poloxamer Industry Trends
- 10.2 Poloxamer Industry Drivers
- 10.3 Poloxamer Industry Opportunities and Challenges
- 10.4 Poloxamer Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst